This report presents a strategic analysis of the Africa Contraceptive Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Africa Contraceptive Devices Market, offering unmatched value, accuracy and expert insights.
Africa is the second-largest continent in terms of land and population, after Asia. It covers one-fifth of the planet's land area and is home to 14% of the world's inhabitants. It is rapidly growing and improving in every field, and the world's attention is steadily shifting to the continent over time.
Recognized as one of the most diversified lands, Africa homes a population that comes from different nationalities, identities, and cultures. Diversity is in the very nature of Africa and this is exactly what makes it complicated to provide quality healthcare. Furthermore, healthcare providers face difficulties such as inconsistent development, a lack of infrastructure, and overall healthcare resource education and development. A noticeable difference in healthcare facilities as well as brain drain as experienced healthcare personnel leave Africa in search of a higher standard of living. Revenue in the Health Care segment is projected to reach US$664.20m in 2022
Revenue is expected to show an annual growth rate (CAGR 2022-2025) of 17.04%, resulting in a projected market volume of US$1,065.00m by 2025In the Health Care segment, the number of users is expected to amount to 137.1m users by 2025.
To develop universal health care, deal with medical emergencies, and encourage healthier populations, access to high-quality, reasonably priced, and suitable health products is essential.
Without medical devices, it would be impossible to do regular medical procedures like bandaging a damaged ankle, diagnosing HIV/AIDS, implanting an artificial hip, or performing any type of surgery. Medical gadgets are utilized by laypeople at home, paramedical workers and clinicians at outlying clinics, optometrists, dentists, and healthcare professionals in cutting-edge medical facilities, for screening and prevention, as well as in palliative care. These medical technologies are employed in the diagnosis and treatment of acute and chronic illnesses, as well as in the support of persons with disabilities.
The contraceptive industry is both numerous and highly fragmented. Since there is a lack of knowledge about the benefits of contraceptives in emerging economies, market participants should start working with governments to build collaborative agreements to inform women and related individuals about various choices. Affordable contraceptive methods should be produced more by manufacturers to enhance their use in emerging economies.
The Global Contraceptive Devices Market size is at around US $ 9.0 Bn in 2021 and is projected to reach US $ 23.72 Bn in 2030, exhibiting a CAGR of 7.2% during the forecast period.
Market Growth Drivers Analysis
The key factors leading to the development of the contraception industry are the imperative of reducing unplanned pregnancies and their consequences. One of the major drivers for this demand is the need to prevent unwanted pregnancies, particularly among teenage women
Market Restraints
The side effects associated with the use of contraceptives and the high cost of treatment may impede the growth of the market.
Key Players
Some companies currently dominating the market are Bayer AG, Mayer Laboratories, Inc., Reckitt Benckiser Group plc, CooperSurgical, Inc., and AbbVie
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population
By Gender (Revenue, USD Billion):
Based on Gender the contraceptive devices market is segmented into male and female.
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.